A 3-year-old toddler with a recent episode of bloody diarrhea is admitted to the pediatric unit with suspected hemolytic-uremic syndrome (HUS). Which assessment finding would be most indicative of this condition?

Hemolytic-uremic syndrome is a thrombotic microangiopathy (TMA) characterized by a classic triad of clinical and laboratory findings. The condition is most often triggered by Shiga toxin-producing bacteria following a gastrointestinal infection, leading to endothelial injury, particularly in the kidneys. The primary pathological process involves the formation of microthrombi in small blood vessels, which consumes platelets and mechanically damages red blood cells as they pass through narrowed, clot-filled vessels ^[1][4].

The assessment finding most indicative of HUS is schistocytes on peripheral blood smear with decreased hematocrit. This finding directly reflects the core component of microangiopathic hemolytic anemia (MAHA), which is a defining feature of the HUS triad ^[1][3]. Schistocytes are fragmented red blood cells created by the mechanical shearing force exerted on erythrocytes as they traverse platelet-rich microthrombi in the microvasculature. The destruction of these red blood cells (hemolysis) leads directly to a decreased hematocrit. This is not just a supportive lab value; it is a direct visualization of the underlying disease mechanism ^[4].

• 
  Option 1: An elevated white blood cell count with a left shift is a non-specific marker of inflammation or infection. While a preceding bacterial gastroenteritis is common in typical HUS, this finding is not a defining characteristic of the syndrome itself, which is defined by the triad of hemolytic anemia, thrombocytopenia, and acute kidney injury ^[1].
  


• 
  Option 2: Hypertension accompanied by peripheral and periorbital edema is a classic presentation of acute glomerulonephritis or nephrotic syndrome, often related to fluid overload and sodium retention from primary kidney dysfunction. While acute kidney injury is a component of HUS, the edema in HUS is more directly related to oliguric renal failure, and this presentation is not as pathognomonic as the hematologic findings. The core problem in HUS is the microangiopathy, not a primary glomerular inflammatory process ^[1][2].
  


• 
  Option 3: A decreased platelet count with scattered petechiae is a very common finding in HUS and represents the thrombocytopenia component of the triad ^[1][2]. However, thrombocytopenia alone is not the most specific indicator. Many conditions, such as immune thrombocytopenic purpura (ITP), can cause low platelets and petechiae without the microangiopathic hemolytic anemia that defines HUS. The presence of schistocytes confirms that the thrombocytopenia is due to consumption in microthrombi (a TMA process), not just immune destruction or underproduction.
  

For a definitive diagnosis of HUS, you must see evidence of the full triad. While thrombocytopenia (Option 3) and acute kidney injury (which could manifest as the edema in Option 2) are essential, the presence of schistocytes on a peripheral smear with a falling hematocrit is the most specific finding that distinguishes a thrombotic microangiopathy like HUS from simple hemolysis or isolated platelet disorders. The schistocyte is the hallmark laboratory evidence of mechanical red cell destruction, confirming the microangiopathic process. A decreased hematocrit is the direct consequence of this hemolysis, and together they represent the non-immune, mechanical hemolytic anemia that is central to the syndrome's pathophysiology ^[3][4].